Mesoblast Limited

MESO ·Healthcare, Drug Manufacturers - General, Australia
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $733.6M

Liabilities Breakdown FY2020

Total Liabilities: $184.3M